(Q78725176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

M Marchand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

C J A Punt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

S Aamdal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

B Escudier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

W H J Kruit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

U Keilholz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

L Håkansson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

N van Baren

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Y Humblet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

P Mulders

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

M-F Avril

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

A M M Eggermont

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

C Scheibenbogen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J Uiters

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J Wanders

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

M Delire

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

T Boon

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

G Stoter

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

70-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Biological and clinical developments in melanoma vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Therapeutic potential of protein and adjuvant vaccinations on tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900479-3

7 January 2021

10.1016/S0959-8049(02)00479-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504661%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference